Rigel Pharmaceuticals | RIGL - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Arrowhead Research USD 9.05M 1.97M 2025-09
AstraZeneca USD 85M 17M 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Intrexon USD 319K 602K 2024-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 3.87M 2.25M 2025-09
MacroGenics USD 1.53M 114K 2025-09
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Veracyte USD 3.48M 545K 2025-09